| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |